Clinical trials on hereditary angioedema and primary immunodeficiency disease

Clinical trials on asthma, urticaria (hives or itch), food allergies (e.g. Alpha-gal), and rare disorders such as hereditary angioedema and primary immunodeficiency disease are among those being conducted. Scientific studies on the human microbiome and its impact in asthma and urinary tract infections are also underway.

Furthermore, our experts are investigating adverse reactions to COVID-19 vaccinations. Among the numerous studies are those conducted under the aegis of the National Institutes of Health and those funded by the division or pharmaceutical corporations.

    Related Conference of Clinical trials on hereditary angioedema and primary immunodeficiency disease

    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 19-20, 2025

    18th World Drug Delivery Summit

    Aix-en-Provence, France
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Paris, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Clinical trials on hereditary angioedema and primary immunodeficiency disease Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in